Story perspectives

Trump and Kennedy Promote Unproven Autism Treatment, Prescriptions Surge 71%

3/22/2026

Summary

Story summary

U.S. President Donald Trump and Robert F. Kennedy Jr. promoted leucovorin as autism treatment in March 2026, despite limited evidence.
Prescriptions for leucovorin rose 71% after the announcement.
The Food and Drug Administration (FDA) approved leucovorin only for cerebral folate deficiency.
Experts including William Graf criticized the lack of research and ethics; the American Academy of Pediatrics advised against leucovorin for autism.
Critics warn misinformation undermines trust in public health.

1 of 1

Story summary

U.S. President Donald Trump and Robert F. Kennedy Jr. promoted leucovorin as autism treatment in March 2026, despite limited evidence.
Prescriptions for leucovorin rose 71% after the announcement.
The Food and Drug Administration (FDA) approved leucovorin only for cerebral folate deficiency.
Experts including William Graf criticized the lack of research and ethics; the American Academy of Pediatrics advised against leucovorin for autism.
Critics warn misinformation undermines trust in public health.